Natsudaidai (Citrus natsudaidai Hayata): A Comprehensive Reference
1. Identity and Botanical Classification
Accepted Scientific Name and Synonymy
The formally accepted scientific name is Citrus natsudaidai Hayata, classified within the family Rutaceae, subfamily Aurantioideae, genus Citrus, first described by Hayata in 1919. The name is treated by some authoritative sources, including Kew's Plants of the World Online, as a synonym of Citrus × aurantium f. aurantium. The NCBI taxonomy database registers it as a distinct species-level taxon under Citrus.
In Japanese, the fruit is most widely known as natsumikan (ナツミカン, 夏蜜柑) or natsudaidai (ナツダイダイ, 夏橙). In Japanese, natsu means "summer" and mikan means "citrus," giving natsumikan the meaning of "summer citrus." The fruit is also occasionally referred to as amanatsu in the context of a specific cultivar derived from it (see below).
Botanical Origin and Natural Habitat
Natsudaidai is believed to have originated from a seed that drifted ashore in Yamaguchi Prefecture, Japan, around 1870, and appears to be a hybrid of pummelo and another citrus species. The original plant is said to have been found in a garden in Yamaguchi Prefecture and is reported to still be alive. The variety may be a natural hybrid of the sour orange and the mandarin, or of the pomelo and the sour orange.
In Japan, natsudaidai is grown in the coastal prefectures of Kumamoto and Ehime due to its sensitivity to low temperatures, and it is second in importance only to the satsuma mandarin. It is described as the second most important citrus fruit in Japan, having been formally registered in 1950; harvesting begins in April and ends in May, and it is a frost-hardy plant.
Physical Description
The natsudaidai tree is vigorous, with assurgent, spreading growth, few but thick thorns, and broad dark green leaves. The fruit is medium-large (similar to a grapefruit), oblate or obovate in shape, and sporadically exhibits a small pedicel lobe. The fruit contains 12 segments and about 30 seeds. The rough-textured fruit is easy to peel and is commonly eaten fresh.
Related Cultivar: Amanatsu
Amanatsu (甘夏) is a yellow citrus fruit and a cultivar that originated as a mutation of the natsumikan (natsu daidai); it was discovered in 1935 in Tsukumi, Oita Prefecture, Japan. While closely related, amanatsu is a distinct horticultural variety rather than a synonym for C. natsudaidai itself.
Common Forms and Preparations
Like all trees of the Rutaceae family, the fruit is used industrially by food, cosmetic, and pharmaceutical companies. Preparations documented in research contexts include:
- Peel extracts (immature and mature): Methanol, ethanol, hexane, butanol, ethyl acetate, and water fractions prepared from air-dried peel, used in pharmacological studies.
- Essential oil: The main components of natsudaidai essential oil are the well-known terpenes limonene (80%), γ-terpinene (5%), myrcene (2%), and α-pinene (1%).
- Dried immature fruit (Kijitsu): Constituents of citrus plants, such as Aurantii Fructus Immaturus (Kijitsu) prepared from dried immature fruits of Citrus aurantium var. daidai and C. natsudaidai, have been used to develop useful crude drugs.
- Cosmetic peel extract: Used as a humectant and skin-conditioning agent in topical formulations.
2. Traditional and Historical Use
Japan: Culinary and Medicinal Context
Citrus natsudaidai (natsumikan) has been a famous citrus fruit recognized for its medical properties in many countries. Because natsumikan contains a large amount of antioxidative nutrients such as Vitamin C and flavonoids, regular consumption of citrus fruit has been considered good for maintaining health.
Natsu daidai is often used in Japanese cuisine, particularly in traditional dishes and confections. Its peel is highly aromatic and is commonly used as a flavoring agent in sauces, marinades, and dressings; the zest can be grated or finely sliced and added to dishes to impart its unique citrus fragrance.
Kampo Medicine: Kijitsu
Citrus natsudaidai Hayata is recognized as one of the standard source species for the Kampo crude drug Kijitsu (枳実), alongside Citrus aurantium L. var. daidai Makino and Citrus sinensis Osbeck. Kijitsu refers to the dried immature fruit and is a recognized drug ingredient in Japanese traditional medicine.
Kijitsu is prepared as a 50% ethanolic extract of dried immature citrus fruits from C. natsudaidai Hayata and related species. In vitro experiments revealed weak toxicities, weak intestinal or uterine relaxant activities, and beta-adrenergic activities, with antiasthmatic activity observed upon intraperitoneal administration.
Natsudaidai, a citrus fruit native to Japan, has traditionally been used in Japanese and East Asian folk medicine for a variety of purposes, including as a remedy to support appetite, particularly in cases of appetite deficiency. Most available evidence for such traditional uses is anecdotal or based on the traditional reputation of citrus fruits and their peels, with some studies on related species suggesting possible digestive benefits; however, such findings cannot be directly applied to natsudaidai without further research. While its use for appetite support is rooted in tradition, rigorous clinical or preclinical evidence is lacking.
3. Key Constituents and Active Compounds
Flavonoids (Flavanone Glycosides)
Natsumikan is rich in many bioactive components, including hesperidin, neohesperidin, naringin, nobiletin, tangeretin, and auraptene, which have all been well studied for their pharmacological anti-inflammatory, anticarcinogenic, and antioxidant properties.
A quantitative analysis of the immature natsumikan peel established the following concentrations per 100 g: hesperidin 11 mg, neohesperidin 370 mg, naringin 780 mg, nobiletin 1.6 mg, tangeretin 3.2 mg, and auraptene 26 mg.
Natsumikan peel contains a higher concentration of neohesperidin and naringin than other citrus species. This elevated flavanone glycoside profile is a defining phytochemical characteristic of the species relative to its relatives.
The flavonoid content of the dried immature fruit (Kijitsu) includes narirutin, naringin, hesperidin, and neohesperidin, as well as synephrine; concentrations did not differ substantially between C. natsudaidai and closely related Citrus species used as Kijitsu substitutes.
Coumarins
Auraptene (7-geranyloxycoumarin), previously identified as an inhibitor of 12-O-tetradecanoylphorbol-13-acetate-induced Epstein-Barr virus activation, occurs in a variety of citrus fruits including natsumikan (Citrus natsudaidai). Auraptene is present in both the peel and essential oil fractions.
Essential Oil Terpenes
The main components of natsudaidai essential oil include limonene (80%), γ-terpinene (5%), myrcene (2%), and α-pinene (1%). These monoterpenes are characteristic of citrus essential oils broadly and are responsible for the fruit's aromatic profile.
Other Constituents
Natsudaidai contains numerous components of interest to human health, including flavonoids, terpenes, linalool, vitamin C, and folic acid, with antioxidant properties. Several antioxidative nutrients are found in higher concentration in the peel than in the pulp of the fruit.
Established Mechanisms of Action of Key Constituents
The bioactivities of natsudaidai are attributed primarily to its constituent flavonoids and coumarins. The mechanisms identified in the published literature include:
- Antioxidant activity: Citrus flavonoids, including naringin and its aglycone naringenin, display strong anti-inflammatory and antioxidant activities.
- NF-κB inhibition: Molecular docking analyses predict that naringin and neohesperidin inhibit NF-κB, and that hesperidin, neohesperidin, narirutin, naringin, apigenin, kaempferol, quercetin, rutin, eriocitrin, sinensetin, and vitamin A can inhibit the soluble epoxide hydrolase (sEH) enzyme.
- BDNF upregulation: An increase in brain-derived neurotrophic factor (BDNF) in the brain is beneficial for the treatment of depression, Alzheimer's disease, and Parkinson's disease; BDNF can cross the blood-brain barrier. Foods that elevate BDNF concentration in peripheral tissues may thereby increase BDNF in the brain.
- Antitumor and proapoptotic effects of auraptene: Auraptene is a coumarin derivative extracted from citrus species; to date, it has shown antioxidant, antibacterial, anti-inflammatory, antiproliferative, antiapoptotic, and antitumor activities.
- Metabolic / antidiabetic effects: Several lines of investigation suggest that naringin supplementation may be beneficial for the treatment of obesity, diabetes, hypertension, and metabolic syndrome, with a number of molecular mechanisms underlying its beneficial activities having been elucidated; however, its effect on obesity and metabolic disorder remains to be fully established, and therapeutic uses of these flavonoids are significantly limited by the lack of adequate clinical evidence.
4. Scientific Evidence by Area of Use
4.1 Allergic and Inflammatory Skin Conditions
The most directly studied application for C. natsudaidai peel extract is experimental allergic dermatitis.
Study (Animal, 2011): A study examined whether extract from immature natsumikan peel prevents the development of chronic allergic dermatitis in mice. Chronic allergic dermatitis was induced by repeated application of 2,4,6-trinitro-1-chlorobenzene in BALB/c mice, and natsumikan was administered orally for 30 days; ear swelling and dermatitis score were measured after each challenge, and serum levels of derivative-reactive oxygen metabolites (d-ROM) were measured on day 30.
Treatment of natsumikan significantly attenuated the increase in ear swelling and improved dermatitis scores; increases in serum d-ROM were also attenuated by natsumikan treatment. Importantly, while routine treatment with dexamethasone resulted in a clear and significant reduction in body weight, natsumikan treatment did not have such an effect.
Evidence strength: This is a single preclinical (murine) study with no human clinical data. Findings support the hypothesis that the anti-allergic effect may be mediated at least in part through antioxidant mechanisms but cannot be extrapolated to clinical application.
4.2 Hepatoprotection
Study (Animal, 2012): A high dose of acetaminophen (APAP) generates highly reactive intermediates and causes fatal liver injury. Researchers examined whether an extract from immature natsumikan peel prevents lethal hepatotoxicity induced by a lethal dose of APAP in mice. Male ICR mice were treated orally with natsumikan extract at doses of 300 and 1,000 mg/kg at 2, 26, and 50 hours before a single oral administration of APAP (300 mg/kg).
Following administration of 300 mg/kg APAP, all mice died within 6 hours. However, pretreatment with natsumikan extract (300 and 1,000 mg/kg) or silymarin (300 and 1,000 mg/kg) increased the survival rate to 16.7%, 33.3%, 16.7%, and 50%, respectively, at 24 hours.
The extract of immature natsumikan peel was previously effective for treating chronic allergic contact dermatitis, and this effect might be mediated by its antioxidative properties. It can be assumed that the inhibitory effect of natsumikan on APAP-induced hepatotoxicity is mediated, at least in part, by its antioxidative properties. The researchers hypothesized that the antioxidative elements of natsumikan may be hesperidin and naringin, but further studies are required to confirm this.
Evidence strength: Preclinical animal study only. No human data exist on this specific application for natsudaidai.
4.3 Neurological Effects — BDNF Upregulation
Study (In vitro, 2023): Methanol extracts of C. natsudaidai peel and pulp and their n-hexane, ethyl acetate, n-butanol, and water fractions were prepared and tested for BDNF production by measuring BDNF levels in the culture medium of human kidney adenocarcinoma (ACHN) cells after 24-hour cultivation. BDNF concentration increased in the culture medium of ACHN cells treated with the methanol extract of C. natsudaidai peel and its hexane, butanol, and water fractions, as well as the butanol and water fractions of the pulp extract.
Quantitative reverse transcription-polymerase chain reaction analysis revealed that ACHN cells treated with the butanol fractions of the peel and pulp extracts showed elevated levels of BDNF mRNA compared with non-treated cells. The authors proposed that C. natsudaidai may increase BDNF concentration by acting on peripheral tissues and could be a candidate for the prevention and treatment of depression, Alzheimer's disease, and Parkinson's disease.
This finding was referenced in a subsequent study noting that C. natsudaidai increased BDNF level in the ACHN cell line, which has BDNF-producing ability. A reduction in BDNF in the brain causes depression, whereas an increase has therapeutic benefits. BDNF is synthesized in various peripheral tissues and transported to the brain via peripheral circulation across the blood-brain barrier; therefore, substances that upregulate peripheral BDNF may be used to prevent and treat depression.
Evidence strength: In vitro (cell culture) only. No animal models or human studies have been conducted for natsudaidai specifically with respect to neurological endpoints.
4.4 Anticancer / Antiproliferative Properties
Study (In vitro, 2004): Extracts from peels of Citrus natsudaidai encapsulated in hybrid liposomes (HL) composed of L-α-dimyristoylphosphatidylcholine and polyoxyethylene (20) sorbitan monolaurate were examined for growth inhibitory effects on tumor cells. Extracts with lower-polarity solvents inhibited the growth of B-16 mouse melanoma and human lung carcinoma cells, although extracts with higher-polarity solvents showed no antitumor activity. The inhibitory effects of lower-polarity solvent extracts encapsulated in HL were enhanced compared with those of free extracts. Fluorescence microscopic analysis indicated that HL including petroleum ether extracts induced apoptosis in B-16 mouse melanoma cells. The viability of normal human fibroblast cells was even less affected by the extracts of natsumikan. These results suggest that hydrophobic antitumor agents are present in peels of natsumikan.
The coumarin constituent auraptene has received additional attention as a chemopreventive agent in natsudaidai research. The immunomodulatory effects of auraptene isolated from the peel of Citrus natsudaidai Hayata were investigated; female BALB/c mice were gavaged with auraptene at doses of 100, 200, or 400 mg/kg once a day for 10 consecutive days, and glucose consumption of peritoneal macrophages was significantly higher in auraptene-treated mice at all doses at 24, 48, and 72 hours of incubation.
Auraptene has been found to have inhibitory and chemopreventive effects on the proliferation, tumorigenesis, and growth of several cancer cell lines. Many mechanisms of action including anti-inflammatory, antiproliferative, and antiapoptotic effects are being suggested for the chemopreventive properties of auraptene.
Evidence strength: All anticancer evidence for natsudaidai specifically is at the preclinical level (in vitro and animal models). No clinical trials have been conducted on natsudaidai or its isolated constituents for cancer prevention or treatment in humans.
4.5 Antioxidant Activity
Citrus natsudaidai is a typical citrus fruit containing several antioxidative nutrients which are found in higher concentration in the peel than in the pulp. The anti-allergic and hepatoprotective effects observed in animal studies are attributed at least in part to antioxidant mechanisms, specifically the reduction of reactive oxygen metabolites (d-ROM) in serum. All citrus peel preparations tested in flavonoid research have shown stronger antioxidant activity and higher concentrations of flavonoids and phenolics than the flesh. This is consistent with the documented phytochemical profile of natsudaidai peel.
4.6 Metabolic Syndrome, Obesity, and Diabetes
No studies have been conducted with C. natsudaidai extracts or preparations specifically in models of obesity, diabetes, or metabolic syndrome. However, the constituent flavonoids — especially naringin and neohesperidin — have been broadly studied in these contexts. Several lines of investigation suggest naringin supplementation may be beneficial for obesity, diabetes, hypertension, and metabolic syndrome; however, the therapeutic uses of these flavonoids are significantly limited by the lack of adequate clinical evidence. These findings cannot be directly attributed to natsudaidai preparations without dedicated research.
5. Body Systems and Health Areas Associated with Natsudaidai
- Immune / Dermatological system: Anti-allergic effects in experimental dermatitis; reduction of oxidative stress markers in vivo (preclinical evidence).
- Hepatic system: Hepatoprotective activity against acetaminophen-induced hepatotoxicity in mice (preclinical evidence).
- Central nervous system: BDNF upregulation in peripheral cell lines; candidate application in depression and neurodegeneration (in vitro evidence only).
- Oncology (experimental): Antiproliferative and apoptosis-inducing effects on melanoma and lung carcinoma cell lines in vitro; immunomodulatory effects of auraptene in mice.
- Metabolic / Cardiovascular: Putative benefits attributable to naringin and neohesperidin constituents; no species-specific human evidence.
- Digestive system: Weak intestinal relaxant activities and beta-adrenergic activities observed for Kijitsu (dried immature C. natsudaidai) extracts in vitro.
- Skin (topical): Used as a humectant and skin-conditioning agent in cosmetic formulations.
6. Dosage Forms and Dosages Reported in Studies
No human clinical trials have established recommended dosages for natsudaidai preparations. All dosage information available comes from preclinical (animal) studies:
- Hepatoprotection (mouse): Male ICR mice were treated orally with natsumikan extract at 300 mg/kg and 1,000 mg/kg, administered at 2, 26, and 50 hours before APAP challenge.
- Allergic dermatitis (mouse): Natsumikan peel extract was administered orally for 30 days in BALB/c mice sensitized with TNCB. Specific mg/kg dosage is not reported in the available abstracts.
- Auraptene immunomodulation (mouse): Auraptene isolated from the peel of Citrus natsudaidai was administered by gavage to female BALB/c mice at 100, 200, or 400 mg/kg once daily for 10 consecutive days.
- BDNF study (in vitro): Methanol extracts and fractions of C. natsudaidai peel and pulp were tested in ACHN cell cultures over 24-hour cultivation periods. No equivalent oral dosage can be inferred from in vitro data.
7. Safety Considerations and Drug Interactions
General Safety Profile
Studies on the Kijitsu preparation from C. natsudaidai showed only weak toxicities in vitro; these activities did not differ between natsudaidai and closely related species used as substitutes. In the hepatotoxicity study, the viability of normal human fibroblast cells was less affected by natsumikan extracts compared to tumor cells, suggesting some degree of selectivity in cytotoxicity. However, no formal human safety data or clinical toxicology assessments for natsudaidai preparations have been published.
Drug Interactions via CYP Enzymes
Natsudaidai contains naringin and neohesperidin at notably high levels, and these flavonoids — as well as furanocoumarins present in related citrus species — are known to interact with drug-metabolizing enzymes. Flavonoids can interact with the metabolizing enzymes of xenobiotics, such as cytochrome P450 enzymes. Many prescription drugs are substrates of these efflux transporters and metabolizing enzymes, and flavonoid–drug interactions include induction or inhibition of metabolizing enzymes and drug efflux proteins, leading to higher or subtherapeutic plasma drug concentrations or absorption changes.
The action of flavonoids, in particular naringin, on membrane transporters inhibits organic anion-transporting polypeptides (OATPs), resulting in a transient decrease in the bioavailability of certain drugs.
Immature orange (Aurantii fructus immaturus) and citrus unshiu peel are common ingredients of Kampo formulations, and a previous study reported that Kampo containing these ingredients decreased the blood concentration of concomitant drugs via upregulation of CYP3A4; some flavonoids are indicated to alter P-gp and CYP3A4 activity via changes in pregnane X receptor (PXR) activity. Because C. natsudaidai is a recognized source species for Aurantii fructus immaturus (Kijitsu), this interaction profile is directly relevant.
Studies have shown that repeated administration of flavonoids causes down-regulation of cytochrome P450 enzymes and up-regulation of uridine diphosphate glucuronosyltransferases (UGT), with both increased and decreased drug plasma levels having been reported depending on the nutraceutical type and route of administration.
Bioavailability Limitations
Oral bioavailability of citrus flavonoid glycosides varies substantially by form: unmodified glycosides often show less than 10% systemic exposure to parent aglycone equivalents, while aglycone-enriched or phytosome formulations commonly report multi-fold improvements. This limits the direct clinical translation of in vitro and animal findings.
Uterine Activity
Kijitsu prepared from C. natsudaidai demonstrated weak uterine relaxant activity in vitro. This finding, though from a low-powered early study, indicates a potential pharmacological effect on uterine smooth muscle that warrants attention in relevant populations.
Photosensitivity Potential
Citrus species related to natsudaidai contain furanocoumarins, which are known to have phototoxic potential. While furanocoumarins have not been specifically quantified in natsudaidai in the available literature, auraptene itself is a geranyloxycoumarin, and the presence of related coumarin structures in the peel extract is established. Citrus fruits contain polyphenols which may include furanocoumarins such as bergamottin, dihydroxybergamottin, and bergapten. Whether these are present in phototoxic concentrations in natsudaidai has not been specifically established.
8. Summary of Evidence Quality
Research specifically on Citrus natsudaidai as a supplement or pharmacological agent remains at an early, predominantly preclinical stage. The body of evidence consists of a small number of animal studies and in vitro experiments, with no published randomized controlled trials or systematic reviews targeting this species directly. Most available evidence is anecdotal or based on the traditional reputation of citrus fruits and their peels, with some studies on related species suggesting possible digestive benefits; such findings cannot be directly applied to natsudaidai without further research, and its effectiveness for most claimed applications remains primarily a matter of traditional practice rather than scientific validation. The strongest experimental signals from the peer-reviewed literature are in the areas of anti-allergic dermatitis activity and hepatoprotection (both murine models), and BDNF upregulation (in vitro). Evidence for anticancer and metabolic effects is indirect, deriving from studies of isolated constituents, not whole natsudaidai preparations, in human subjects.
References
Go back